Annual Change in Pulmonary Function and Clinical Characteristics of Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis: Over a 3-Year Follow-up
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yu Jin | - |
dc.contributor.author | Shin, Seong Hyun | - |
dc.contributor.author | Park, Jeong-Woong | - |
dc.contributor.author | Kyung, Sun Young | - |
dc.contributor.author | Kang, Shin Myung | - |
dc.contributor.author | Lee, Sang-Pyo | - |
dc.contributor.author | Sung, Yon Mi | - |
dc.contributor.author | Kim, Yoon Kyung | - |
dc.contributor.author | Jeong, Sung Hwan | - |
dc.date.available | 2020-02-28T18:46:34Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2014-07 | - |
dc.identifier.issn | 1738-3536 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/13087 | - |
dc.description.abstract | Background: Combined pulmonary fibrosis and emphysema (CPFE) have different pulmonary function tests (PFTs) and outcomes than idiopathic pulmonary fibrosis (IPF). The intention of this study was to identify unknown differences between CPFE and IPF by a retrospective comparison of clinical data including baseline and annual changes in pulmonary function, comorbidities, laboratory findings, clinical characteristics and cause of hospitalization. Methods: This study retrospectively enrolled patients with CPFE and IPF who had undergone PFTs once or several times per year during a follow-up period of three years. Baseline clinical characteristics and the annual changes in the pulmonary function during the follow-up period were compared between 26 with CPFE and 42 patients with IPF. Results: The baseline ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC%) in patients with CPFE was lower than that in patients with IPF (78.6±1.7 vs. 82.9±1.1, p=0.041). The annual decrease in FEV1/FVC in the CPFE was significantly higher than in the IPF. The annual decreases in diffusion capacity of carbon monoxide and FVC showed no significant differences between the two groups. The symptom durations of cough and sputum were in the CPFE significantly lower than in the IPF. The serum erythrocyte sedimentation rate level at the acute stage was significantly higher than in the IPF. There were no significant differences in the hospitalization rate and pneumonia was the most common cause of hospitalization in both study groups. Conclusion: The annual decrease of FEV1/FVC was in patients with CPFE significantly higher than in the patients with IPF. Copyright © 2014 The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean National Tuberculosis Association | - |
dc.relation.isPartOf | Tuberculosis and Respiratory Diseases | - |
dc.title | Annual Change in Pulmonary Function and Clinical Characteristics of Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis: Over a 3-Year Follow-up | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.doi | 10.4046/trd.2014.77.1.18 | - |
dc.identifier.bibliographicCitation | Tuberculosis and Respiratory Diseases, v.77, no.1, pp.18 - 23 | - |
dc.identifier.kciid | ART001898141 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84906318288 | - |
dc.citation.endPage | 23 | - |
dc.citation.startPage | 18 | - |
dc.citation.title | Tuberculosis and Respiratory Diseases | - |
dc.citation.volume | 77 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Kim, Yu Jin | - |
dc.contributor.affiliatedAuthor | Shin, Seong Hyun | - |
dc.contributor.affiliatedAuthor | Park, Jeong-Woong | - |
dc.contributor.affiliatedAuthor | Kyung, Sun Young | - |
dc.contributor.affiliatedAuthor | Kang, Shin Myung | - |
dc.contributor.affiliatedAuthor | Lee, Sang-Pyo | - |
dc.contributor.affiliatedAuthor | Sung, Yon Mi | - |
dc.contributor.affiliatedAuthor | Kim, Yoon Kyung | - |
dc.contributor.affiliatedAuthor | Jeong, Sung Hwan | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Idiopathic pulmonary fibrosis | - |
dc.subject.keywordAuthor | Pulmonary emphysema | - |
dc.subject.keywordAuthor | Pulmonary fibrosis | - |
dc.subject.keywordAuthor | Respiratory function tests | - |
dc.subject.keywordPlus | acetylcysteine | - |
dc.subject.keywordPlus | beta adrenergic receptor stimulating agent | - |
dc.subject.keywordPlus | carbon monoxide | - |
dc.subject.keywordPlus | cholinergic receptor blocking agent | - |
dc.subject.keywordPlus | prednisolone | - |
dc.subject.keywordPlus | theophylline | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | clinical article | - |
dc.subject.keywordPlus | combined pulmonary fibrosis and emphysema | - |
dc.subject.keywordPlus | comorbidity | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | coughing | - |
dc.subject.keywordPlus | disease duration | - |
dc.subject.keywordPlus | erythrocyte sedimentation rate | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | fibrosing alveolitis | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | forced expiratory volume | - |
dc.subject.keywordPlus | forced vital capacity | - |
dc.subject.keywordPlus | hospitalization | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | laboratory test | - |
dc.subject.keywordPlus | lung diffusion capacity | - |
dc.subject.keywordPlus | lung emphysema | - |
dc.subject.keywordPlus | lung fibrosis | - |
dc.subject.keywordPlus | lung function test | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | pneumonia | - |
dc.subject.keywordPlus | retrospective study | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.